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Abstract
Revascularization remains the most intuitive strategy to reverse ischemic injury associated with
arterial occlusion in acute stroke. Revascularization may lead to opening of an occluded artery, or
recanalization, yet restoration of downstream flow, or reperfusion, may not ensue. Revascularization
strategies and novel devices continue to broaden options for the treatment of acute stroke, but it is
increasingly apparent that selection criteria to identify ideal cases are needed to refine triage and
minimize adverse events. The results of recent work on reperfusion may rapidly alter routine clinical
practice for evolving ischemia in the brain.
Introduction and context
Ischemia in the brain may result from diverse mechan-
isms, although blockage of an artery with a clot or
progressive narrowing due to atherosclerosis is the most
common. Such occlusions in proximal arteries at the
base of the brain may be targeted with numerous
revascularization approaches, from systemic thrombo-
lysis to endovascular clot manipulation, in order to
restore perfusion. Revascularization remains the most
intuitive strategy to reverse ischemic injury associated
with arterial occlusion in acute stroke [1]. Revascular-
ization may lead to opening of an occluded artery, or
recanalization, yet restoration of downstream flow, or
reperfusion, may not ensue (Figure 1) [2]. Novel devices
and related procedures are rapidly evolving, but
effective reperfusion with reversal of all neurological
deficits remains an elusive goal [3].
Recent advances
The last year has yielded several important publica-
tions relating to the quandary over current limits
in reperfusion for acute ischemic stroke. The natural
focus is often placed on the type of device or drug
used, ascribing blame or credit to this one piece of
the puzzle. Much remains unclear, however, in such
comparisons regarding one mode of therapy or
another.
The potential biases and need to maintain equipoise
were recently reinstated in a detailed overview of the
topic [4]. It has been argued that equipoise should be
bolstered by enrolling patients in clinical trials that
successively incorporate new interventions [4].
The potential role of intravenous thrombolysis for
recanalization of various occlusion sites has also been
examined in depth [5]. In the Echoplanar Imaging
Thrombolytic Evaluation Trial, intravenous tissue plas-
minogen activator administered in the 3- to 6-hour time
window showed poor recanalization of intracranial
carotid artery (ICA) lesions and far better results with
middle cerebral artery (MCA) occlusions [5]. The
treatment benefit of tissue plasminogen activator over
placebo in limiting infarct evolution was greater for MCA
than for ICA obstruction (P = 0.060). Good clinical
outcome was also more likely with MCA than with ICA
occlusion (P = 0.005). It should be noted that these
definitions were based on noninvasive magnetic reso-
nance angiography.
This pattern of better recanalization in MCA lesions was
observed in univariate analyses of another study that
looked at occurrence and predictors of futile endovas-
cular recanalization [6]. Interestingly, however, the role
of occlusion site disappeared in multivariate regression
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influential in predicting failed recanalization [6]. Futile
recanalization was associated with age of more than 70
years (odds ratio [OR] 4.4, 95% confidence interval [CI]
1.9-10.5; P = 0.0008) combined with an initial National
Institutes of Health Stroke Scale (NIHSS) score of 10-19
(OR 3.8, 95% CI, 1.7-8.4; P = 0.001), and an initial
NIHSS score of 20 or more (OR 64.4, 95% CI 28.8-144;
P <0.0001) regardless of age. Perhaps the extent of
early ischemic changes in baseline imaging may be
influential, as well [7]. Patients with a baseline NIHSS
score of 10-19 may in fact be ideal candidates for
endovascular interventions if the patients have small
cores with proximal occlusions.
Accurate predictors of futile recanalization may be
important in tailoring endovascular procedures and
knowing when to cease attempts at opening an artery.
Another study looked at the critical number of passes to
be used with the Merci Retriever System (Concentric
Medical, Inc., Mountain View, CA, USA), noting that
more than three thrombectomy attempts may be the
cutoff [8]. When at least four attempts were performed,
the final result was more often failed revascularization
and procedural complications (P = 0.006) [8].
Such limitations with novel devices must be considered
as new technology and methods are introduced. A recent
report on the use of the Enterprise stent (Cordis
Corporation, Bridgewater, NJ, USA) in just over a
handful of patients reported successful angiographic
reperfusion scores in all, yet the limitations of the scale
parameter used (e.g., Thrombolysis in Cerebral Infarc-
tion [TICI] score of 2 or more) may not be synonymous
with full reperfusion [9].
Another study demonstrated appropriately defined
reperfusion success, defining successful reperfusion as a
TICI grade of 2b or 3 in 18 of 20 (90%) vessels treated
with the Solitaire stent (ev3 Inc., Plymouth, MN, USA)
Figure 1. Perfusion angiography of revascularization
This novel method to measure blood flow from conventional angiography chronicles both recanalization and associated reperfusion in acute stroke.
Baseline (top row) and post-revascularization (bottom row) images display changes in cerebral blood flow (CBF), cerebral blood volume (CBV), mean
transit time (MTT), and cerebral perfusion pressure (CPP).
Page 2 of 4
(page number not for citation purposes)
F1000 Medicine Reports 2010, 2:71 http://f1000.com/reports/medicine/content/2/71[10]. Baseline imaging patterns, such as the extent of
cerebral blood volume abnormalities, have also recently
proven to predict fatal outcomes [11] and ultimately
may prove to be very important in proper case selection
[12]. Presumably, such variation is due to underlying
differences in the potential of collateral compensation,
and future diagnostic strategies may be able to better
discern these key features [13]. Following revasculariza-
tion, reperfusion more accurately predicts infarct growth
than recanalization does [14].
Future interventions, such as decompressive hemicra-
niectomy, may be used after failed reperfusion. This
surgery is currently reserved for life-threatening massive
infarcts, yet one group suggested that it may be used at an
earlier stage or pre-emptively or as early as possible in
cases of failed multimodal therapy [15].
Finally, understanding the basic mechanisms of reperfu-
sion and improved approaches is also under study.
Mechanisms such as ischemic post-conditioning, in
which gradual reperfusion is employed to obtain
optimal reperfusion, are worthy of further study [16].
Implications for clinical practice
Revascularization strategies and novel devices con-
tinue to broaden options for the treatment of acute
stroke, but it is increasingly apparent that selection
criteria to identify ideal cases are needed to refine
triage and minimize adverse events [17]. Recent study
results reinforce the need to be wary of trial results as
the definitions of reperfusion may vary considerably
[18]. Distinctions between recanalization and reperfu-
sion should be noted. Furthermore, specific angio-
graphic scale features and thresholds to measure
success should be scrutinized. This focus on reperfu-
sion is warranted because it is the closest surrogate of
clinical outcome and the results of recent work on
reperfusion may rapidly alter routine clinical practice
for evolving ischemia in the brain. The topic of
reperfusion is greatly expanding along molecular
mechanisms to animal models to increasing attention
in stroke cases subject to revascularization. Finally, it
should not be forgotten that clinical outcome is
ultimately what matters most. Randomized controlled
studies have yet to unequivocally demonstrate that
novel revascularization and prompt reperfusion
impact outcome.
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